Extrapolation of ACOSOG Z0011 trial results—A survey of breast cancer providers-Reference-Cited by-同舟云学术

Extrapolation of ACOSOG Z0011 trial results—A survey of breast cancer providers

Published:2021-03-15 Issue:6 Volume:27 Page:537-542
ISSN:1075-122X
Container-title:The Breast Journal
language:en
Short-container-title:Breast J

Author:

Weiss Anna¹²³,Cooley Victoria⁴,Al‐Hilli Zahraa⁵,Ballman Karla³⁴,Poorvu Nancy⁶,Haffty Bruce⁷,Hunt Kelly K.³⁸,Nelson Heidi³,Blair Sarah L.³⁹,Boughey Judy³¹⁰

Affiliation:

1. Department of Surgery Division of Breast Surgery Brigham and Women’s Hospital Boston MA USA

2. Breast Oncology Program Dana‐Farber/Brigham and Women’s Cancer Center Boston MA USA

3. Cancer Research Program American College of Surgeons Chicago IL USA

4. Department of Population Health Sciences Division of Biostatistics and Epidemiology Weill Cornell Medicine New York NY USA

5. Department of General Surgery Division of Breast Surgery Cleveland Clinic Foundation Cleveland OH USA

6. Patient Advocate Massachusetts General Hospital/Dana‐Farber Patient Advocate Committee Boston MA USA

7. Department of Radiation Oncology Rutgers Cancer Institute New Brunswick NJ USA

8. Department of Breast Surgical Oncology The University of Texas MD Anderson Cancer Center Houston TX USA

9. Department of Surgery University of California ‐ San Diego San Diego CA USA

10. Department of Surgery Mayo Clinic Rochester MN USA

Publisher

Hindawi Limited

Subject

Oncology,Surgery,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tbj.14226

Reference8 articles.

1. Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node Metastasis

2. Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases

3. Axillary Dissection and Nodal Irradiation Can Be Avoided for Most Node-positive Z0011-eligible Breast Cancers

4. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial

5. Regional Nodal Irradiation in Early-Stage Breast Cancer

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of the positive sentinel lymph node following neoadjuvant chemotherapy: results of a survey conducted with breast surgeons;ecancermedicalscience;2022-02-18

2. Breast cancer—The catalyst of contemporary trials design;Journal of Surgical Oncology;2021-12-13